Discover
SGMO
Sangamo Therapeutics, Inc.
0.07
20000 x 0.08
110000 x 0.09
bid
ask
+
0.00
0.00%
65000 @ 04:00 PM
0.15 +0.07 (98.38%)
| Ytd | -82.38% | |
| 1y | -86.20% |
0.06
day range
0.13
0.06
52 week range
0.77
| Open | 0.13 | Prev Close | 0.07 | Low | 0.06 | High | 0.13 | Mkt Cap | 30.66M |
| Vol | 28.50M | Avg Vol | 9.17M | EPS | -0.38 | P/E | N/A | Forward P/E | -10.86 |
| Beta | 1.10 | Short Ratio | 1.70 | Inst. Own | 27.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.15 | 200-d Avg | 0.37 | 1yr Est | 6.33 |
| Income Statement | |||
| Total Revenue | 14.23M | ||
| Revenues (USD) | 14.23M | ||
| Gross Profit | 14.23M | ||
| Operating Expenses | 52.43M | ||
| Research and Development Expense | 31.44M | ||
| Selling, General and Administrative Expense | 7.76M | ||
| Operating Income | -38.20M | ||
| Income Tax Expense | -553.00K | ||
| Net Income | -37.42M | ||
| Net Income Common Stock | -37.42M | ||
| Net Income Common Stock (USD) | -37.42M | ||
| Consolidated Income | -37.42M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -37.97M | ||
| Earning Before Interest & Taxes (USD) | -37.97M | ||
| Weighted Average Shares | 280.19M | ||
| Weighted Average Shares Diluted | 280.19M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.95M | ||
| Cash and Equivalents (USD) | 20.95M | ||
| Trade and Non-Trade Receivables | 371.00K | ||
| Current Assets | 35.83M | ||
| Property, Plant & Equipment Net | 14.11M | ||
| Total Assets | 59.75M | ||
| Total Debt | 25.09M | ||
| Current Liabilities | 42.47M | ||
| Debt Non-Current | 25.09M | ||
| Total Liabilities | 74.01M | ||
| Accumulated Retained Earnings (Deficit) | -1.63B | ||
| Accumulated Other Comprehensive Income | -1.46M | ||
| Shareholders Equity | -14.27M | ||
| Shareholders Equity (USD) | -14.27M | ||
| Assets Non-Current | 23.92M | ||
| Total Debt (USD) | 25.09M | ||
| Deferred Revenue | 6.77M | ||
| Liabilities Non-Current | 31.55M | ||
| Trade and Non-Trade Payables | 14.44M | ||
| Tax Assets | 19.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.88M | ||
| Net Cash Flow from Financing | 14.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.58M | ||
| Capital Expenditure | -14.00K | ||
| Issuance (Purchase) of Equity Shares | 15.15M | ||
| Net Cash Flow from Investing | -14.00K | ||
| Net Cash Flow from Operations | -24.40M | ||
| Effect of Exchange Rate Changes on Cash | 40.00K | ||
| Share Based Compensation | 2.13M | ||